Weight Gain After Fecal Microbiota Transplantation
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Fecal microbiota transplantation (FMT) is a promising treatment for recurrent Clostridium difficile infection. We report a case of a woman successfully treated with FMT who developed new-onset obesity after receiving stool from a healthy but overweight donor. This case may stimulate further studies on the mechanisms of the nutritional-neural-microbiota axis and reports of outcomes in patients who have used nonideal donors for FMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to modulating immune responses, the composition of commensal microbiota has been linked to chronic diseases, with a theoretical risk of transferring obesity from donor to recipient (30).”
From The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies (2018) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“The hypothesis of FMT triggering or contributing to obesity is supported by animal models demonstrating that an obese microbiota can be transmitted [2].”
Youngster, I., Sauk, J., Pindar, C., Wilson, R. G., Kaplan, J. L., Smith, M. B., Alm, E. J., Gevers, D., Russell, G. H., & Hohmann, E. L. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu135 · Cited by 467 · cited 10×
“She improved and did not suffer a further CDI recurrence after FMT.”
BackgroundInfluentialReview article: associations between Helicobacter pylori and obesity - an ecological study
Lender, N., Talley, N. J., Enck, P., Haag, S., Zipfel, S., Morrison, M., & Holtmann, G. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12790 · Cited by 108
Cited by
Signals from the gut microbiota to distant organs in physiology and disease
Schroeder, B. O., & Bäckhed, F. (2016) · Nature Medicine · doi:10.1038/nm.4185 · Cited by 1,409
Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
“Comment : Treatment response implies clinical improvement, 13 as reduction of stool frequency and improvement of stool consistency, as well as amelioration of other parameters of disease severity as laboratory parameters, radiological and/or endoscopic fi ndings.”
BackgroundThe microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
Zitvogel, L., Ma, Y., Raoult, D., Kroemer, G., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aar6918 · Cited by 777
Ott, S. J., Waetzig, G. H., Rehman, A., Moltzau-Anderson, J., Bharti, R., Grasis, J. A., Cassidy, L., Tholey, A., Fickenscher, H., Seegert, D., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.010 · Cited by 695
The role of the microbiome in cancer development and therapy
Bhatt, A. P., Redinbo, M. R., & Bultman, S. J. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21398 · Cited by 653
“Synthetic FMTs may also prevent certain drawbacks associated with traditional FMTs, such as the potential acquisition of unwanted phenotypes, antibiotic-resistant bacteria, or viruses that evade screening protocols.(142) Metabolic syndrome is increasingly associated with cancer development and resulting mortality.”
BackgroundShen, Z.-H., Zhu, C.-X., Quan, Y.-S., Yang, Z.-Y., Wu, S., Luo, W.-W., Tan, B., & Wang, X.-Y. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i1.5 · Cited by 646
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Fong, W., Li, Q., & Yu, J. (2020) · Oncogene · doi:10.1038/s41388-020-1341-1 · Cited by 613
The microbiota–gut–brain axis in obesity
Torres-Fuentes, C., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30147-4 · Cited by 612
Gut microbiota, obesity and diabetes
Patterson, E., Ryan, P. M., Cryan, J. F., Dinan, T. G., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133285 · Cited by 552
Durable coexistence of donor and recipient strains after fecal microbiota transplantation
Li, S. S., Zhu, A., Benes, V., Costea, P. I., Hercog, R., Hildebrand, F., Huerta-Cepas, J., Nieuwdorp, M., Salojärvi, J., Voigt, A. Y., et al. (2016) · Science · doi:10.1126/science.aad8852 · Cited by 547
Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Aggarwal, N., Kitano, S., Puah, G. R. Y., Kittelmann, S., Hwang, I. Y., & Chang, M. W. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00431 · Cited by 508
Fecal microbiota transplantation: in perspective
Gupta, S., Allen-Vercoe, E., & Petrof, E. O. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15607414 · Cited by 481
Turner, D., Ruemmele, F. M., Orlanski‐Meyer, E., Griffiths, A. M., de Carpi, J. M., Bronsky, J., Veres, G., Aloi, M., Strisciuglio, C., Braegger, C. P., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002035 · Cited by 481
Aron-Wisnewsky, J., Warmbrunn, M. V., Nieuwdorp, M., & Clément, K. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.10.057 · Cited by 452
The microbiome and gynaecological cancer development, prevention and therapy
Łaniewski, P., Ilhan, Z. E., & Herbst-Kralovetz, M. M. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0286-z · Cited by 450
Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction
Bouter, K. E., van Raalte, D. H., Groen, A. K., & Nieuwdorp, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.048 · Cited by 431
The gut microbiome and its role in obesity
Davis, C. D. (2016) · Nutrition Today · doi:10.1097/nt.0000000000000167 · Cited by 407
“A recent case report described a patient who underwent a successful fecal microbial transplant for Clostridium difficile infection but then developed new-onset obesity after receiving stool from an overweight donor.(49)”
BackgroundMénage à trois in the human gut: interactions between host, bacteria and phages
Mirzaei, M. K., & Maurice, C. F. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.30 · Cited by 403
Beyond gut feelings: how the gut microbiota regulates blood pressure
Marques, F. Z., Mackay, C. R., & Kaye, D. M. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.120 · Cited by 397
Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential
Saus, E., Iraola-Guzmán, S., Willis, J. R., Brunet-Vega, A., & Gabaldón, T. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.05.001 · Cited by 350
Gut microbiome and its role in obesity and insulin resistance
Lee, C. J., Sears, C. L., & Maruthur, N. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14107 · Cited by 350
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D. J., Colville, A., Bhala, N., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 332
Vulnerability of the industrialized microbiota
Sonnenburg, J. L., & Sonnenburg, E. D. (2019) · Science · doi:10.1126/science.aaw9255 · Cited by 326
Khanna, S., Pardi, D. S., Kelly, C. R., Kraft, C. S., Dhere, T., Henn, M. R., Lombardo, M.-J., Vulic, M., Ohsumi, T., Winkler, J., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv766 · Cited by 321
Self-citationFecal microbiota transplantation in metabolic syndrome: History, present and future
de Groot, P. F., Frissen, M. N., de Clercq, N. C., & Nieuwdorp, M. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1293224 · Cited by 316
Koh, A., & Bäckhed, F. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.005 · Cited by 309
The gut microbiome and obesity
John, G. K., & Mullin, G. E. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0528-7 · Cited by 304
Microbiota transplantation: Concept, methodology and strategy for its modernization
FMT-standardization Study Group, Zhang, F., Cui, B., He, X., Nie, Y., Wu, K., & Fan, D. (2018) · Protein & Cell · doi:10.1007/s13238-018-0541-8 · Cited by 300
“A woman developed new-onset obesity after receiving stool from a healthy but overweight donor (Alang and Kelly 2015).”
BackgroundMicrobiome: Focus on Causation and Mechanism
Fischbach, M. A. (2018) · Cell · doi:10.1016/j.cell.2018.07.038 · Cited by 252
Zhang, Z., Tang, H., Chen, P., Xie, H., & Tao, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0074-5 · Cited by 251
The influence of the gut microbiome on obesity, metabolic syndrome and gastrointestinal disease
Parekh, P. J., Balart, L. A., & Johnson, D. A. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.16 · Cited by 219
Regulation of energy balance by a gut–brain axis and involvement of the gut microbiota
Bauer, P. V., Hamr, S. C., & Duca, F. A. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2083-z · Cited by 216
Fecal microbiota transplantation in disease therapy
Antushevich, H. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.010 · Cited by 213
Minkoff, N. Z., Aslam, S., Medina, M., Tanner‐Smith, E. E., Zackular, J. P., Acra, S. A., Nicholson, M. R., & Imdad, A. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013871.pub2 · Cited by 205
Design of synthetic human gut microbiome assembly and butyrate production
Clark, R. L., Connors, B. M., Stevenson, D. M., Hromada, S. E., Hamilton, J. J., Amador-Noguez, D., & Venturelli, O. S. (2021) · Nature Communications · doi:10.1038/s41467-021-22938-y · Cited by 204
Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future?
Hanssen, N. M. J., de Vos, W. M., & Nieuwdorp, M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.005 · Cited by 202
Orenstein, R., Dubberke, E., Hardi, R., Ray, A., Mullane, K., Pardi, D. S., & Ramesh, M. S. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ938 · Cited by 197
Gut microbiome and metabolic syndrome
Mazidi, M., Rezaie, P., Kengne, A. P., Mobarhan, M. G., & Ferns, G. A. (2016) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2016.01.024 · Cited by 196
Liu, J., He, Z., Ma, N., & Chen, Z.-Y. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b06817 · Cited by 195
Adverse events in faecal microbiota transplant: a review of the literature
Baxter, M., & Colville, A. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.10.024 · Cited by 185
From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease
McKenney, P. T., & Pamer, E. G. (2015) · Cell · doi:10.1016/j.cell.2015.11.032 · Cited by 181
Gut microbiota: A new target for T2DM prevention and treatment
Liu, L., Zhang, J., Cheng, Y., Zhu, M., Xiao, Z., Ruan, G., & Wei, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.958218 · Cited by 176
Anhê, F. F., Varin, T. V., Le Barz, M., Desjardins, Y., Levy, E., Roy, D., & Marette, A. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0172-9 · Cited by 175
Lee, P., Yacyshyn, B. R., & Yacyshyn, M. B. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13561 · Cited by 151
Considering gut microbiota in treatment of type 2 diabetes mellitus
Adeshirlarijaney, A., & Gewirtz, A. T. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1717719 · Cited by 174
How to: establish and run a stool bank
Terveer, E. M., van Beurden, Y. H., Goorhuis, A., Seegers, J. F. M. L., Bauer, M. P., van Nood, E., Dijkgraaf, M. G. W., Mulder, C. J. J., Vandenbroucke-Grauls, C. M. J. E., Verspaget, H. W., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.05.015 · Cited by 168
Breakthroughs in the treatment and prevention of Clostridium difficile infection
Kociolek, L. K., & Gerding, D. N. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.220 · Cited by 167
Harsch, I. A., & Konturek, P. C. (2018) · Medical Sciences · doi:10.3390/medsci6020032 · Cited by 165
Fecal transplantation for treatment of inflammatory bowel disease
Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O. G., Beaulieu, D. B., & Acra, S. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012774.pub2 · Cited by 164
Morgan, A. E., Mooney, K. M., Wilkinson, S. J., Pickles, N. A., & Mc Auley, M. T. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.03.008 · Cited by 134
Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?
Aron‐Wisnewsky, J., Clément, K., & Nieuwdorp, M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1180-z · Cited by 160
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 159
Fecal transplantation for treatment of inflammatory bowel disease
Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O., Borromeo Beaulieu, D. M., & Acra, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012774 · Cited by 158
Feeding the microbiota: Transducer of nutrient signals for the host
Shanahan, F., van Sinderen, D., O’Toole, P. W., & Stanton, C. (2017) · Gut · doi:10.1136/gutjnl-2017-313872 · Cited by 157
(2015) · PubMed · Cited by 152
Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation.
Marotz, C. A., & Zarrinpar, A. (2016) · PubMed Central · Cited by 151
Linking microbiota to human diseases: a systems biology perspective
Wu, H., Tremaroli, V., & Bäckhed, F. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.09.011 · Cited by 150
Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review
Woodworth, M. H., Carpentieri, C., Sitchenko, K. L., & Kraft, C. S. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1286006 · Cited by 144
Fecal transplantation for treatment of inflammatory bowel disease
Imdad, A., Pandit, N. G., Zaman, M., Minkoff, N. Z., Tanner‐Smith, E. E., Gomez-Duarte, O. G., Acra, S. A., & Nicholson, M. R. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012774.pub3 · Cited by 143
Dailey, F. E., Turse, E. P., Daglilar, E., & Tahan, V. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.04.008 · Cited by 130
Gut Microbiota in Obesity and Undernutrition
de Clercq, N. C., Groen, A. K., Romijn, J. A., & Nieuwdorp, M. (2016) · Advances in Nutrition · doi:10.3945/an.116.012914 · Cited by 140
Davidovics, Z. H., Michail, S., Nicholson, M. R., Kociolek, L. K., Pai, N., Hansen, R., Schwerd, T., Maspons, A., Shamir, R., Szajewska, H., et al. (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002205 · Cited by 126
Gut microbiota and old age: Modulating factors and interventions for healthy longevity
Coman, V., & Vodnar, D. C. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111095 · Cited by 118
The path towards microbiome-based metabolite treatment
Suez, J., & Elinav, E. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.75 · Cited by 137
Osaka, T., Moriyama, E., Arai, S., Date, Y., Yagi, J., Kikuchi, J., & Tsuneda, S. (2017) · Nutrients · doi:10.3390/nu9121329 · Cited by 131
Trubiano, J. A., Cheng, A. C., Korman, T. M., Röder, C., Campbell, A. J., May, M., Blyth, C. C., Ferguson, J., Blackmore, T., Riley, T. V., et al. (2016) · Internal Medicine Journal · doi:10.1111/imj.13027 · Cited by 128
Gut Microbiota: A Contributing Factor to Obesity
Harakeh, S. M., Khan, I., Kumosani, T., Barbour, E., Almasaudi, S. B., Bahijri, S. M., Alfadul, S. M., Ajabnoor, G. M. A., & Azhar, E. I. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00095 · Cited by 107
Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems
Mulders, R. J., de Git, K. C. G., Schéle, E., Dickson, S. L., Sanz, Y., & Adan, R. A. H. (2018) · Obesity Reviews · doi:10.1111/obr.12661 · Cited by 120
Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites
Croci, S., D'Apolito, L. I., Gasperi, V., Catani, M. V., & Savini, I. (2021) · Nutrients · doi:10.3390/nu13051389 · Cited by 121
Costello, S. P., Tucker, E. C., La Brooy, J., Schoeman, M. N., & Andrews, J. M. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ994 · Cited by 105
Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
Tan, P., Li, X., Shen, J., & Feng, Q. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.574533 · Cited by 117
Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms
Ulrich, C. M., Himbert, C., Holowatyj, A. N., & Hursting, S. D. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0053-2 · Cited by 116
del Pozo‐Acebo, L., Hazas, M. L. D. L., Margollés, A., Dávalos, A., & García‐Ruiz, A. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15421 · Cited by 114
Saha, S., Mara, K., Pardi, D. S., & Khanna, S. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.010 · Cited by 101
Hourigan, S. K., Chen, L. A., Grigoryan, Z., Laroche, G., Weidner, M., Sears, C. L., & Oliva‐Hemker, M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13326 · Cited by 101
Malaisé, Y., Menard, S., Cartier, C., Gaultier, E., Lasserre, F., Lencina, C., Harkat, C., Geoffre, N., Lakhal, L., Castan, I., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15196-w · Cited by 107
Antibiotics, gut microbiome and obesity
Leong, K. S. W., Derraik, J. G. B., Hofman, P. L., & Cutfield, W. S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13495 · Cited by 107
Markey, L., Shaban, L., Green, E. R., Lemon, K. P., Mecsas, J. C., & Kumamoto, C. A. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1465158 · Cited by 106
Influence of the Mediterranean Diet on Healthy Aging
Andreo-López, M. C., Contreras-Bolívar, V., Muñoz‐Torres, M., García-Fontana, B., & García‐Fontana, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054491 · Cited by 105
The Human Microbiome and the Missing Heritability Problem
Sandoval-Motta, S., Aldana, M., Martínez-Romero, E., & Frank, A. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00080 · Cited by 90
Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease
Porras, D., Nistal, E., Martínez‐Flórez, S., González‐Gallego, J., García‐Mediavilla, M. V., & Sánchez‐Campos, S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01813 · Cited by 103
Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome
Leshem, A., Horesh, N., & Elinav, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01341 · Cited by 103
Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients
Medina, D. A., Pedreros, J. P., Turiel, D., Quezada, N., Pimentel, F., Escalona, A., & Garrido, D. (2017) · PeerJ · doi:10.7717/peerj.3443 · Cited by 101
“On the 102 other hand, a recent report showed that in one person, fecal microbiota from a healthy but 103 overweight donor induced obesity (Alang & Kelly, 2015).”
BackgroundStanhope, K. L., Goran, M. I., Bosy‐Westphal, A., King, J. C., Schmidt, L. A., Schwarz, J. ‐., Stice, E., Sylvetsky, A. C., Turnbaugh, P. J., Bray, G. A., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12699 · Cited by 87
Nicco, C., Paule, A., Konturek, P. C., & Edeas, M. A. (2020) · Diseases · doi:10.3390/diseases8020009 · Cited by 98
Recent Advances in Understanding the Structure and Function of the Human Microbiome
Mousa, W. K., Chehadeh, F., & Husband, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.825338 · Cited by 98
The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease
Inczefi, O., Bacsúr, P., Resál, T., Keresztes, C., & Molnár, T. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.718710 · Cited by 98
Humanized microbiota mice as a model of recurrent Clostridium difficile disease
Collins, J., Auchtung, J. M., Schaefer, L., Eaton, K. A., & Britton, R. A. (2015) · Microbiome · doi:10.1186/s40168-015-0097-2 · Cited by 98
Oral delivery of bacteria: Basic principles and biomedical applications
Li, S., Jiang, W., Zheng, C., Shao, D., Liu, Y., Huang, S., Han, J., Ding, J., Tao, Y., & Li, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.011 · Cited by 97
Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail
Pigneur, B., & Sokol, H. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.67 · Cited by 96
Therapies to modulate gut microbiota: Past, present and future
Gupta, A., Saha, S., & Khanna, S. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i8.777 · Cited by 94
Prochazkova, P., Roubalova, R., Dvorak, J., Tlaskalova-Hogenova, H., Cermakova, M., Tomasova, P., Sediva, B., Kuzma, M., Bulant, J., Bilej, M., et al. (2019) · Microorganisms · doi:10.3390/microorganisms7090338 · Cited by 93
Wardill, H. R., Secombe, K. R., Bryant, R. V., Hazenberg, M. D., & Costello, S. P. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.03.070 · Cited by 82
Impacts of the Human Gut Microbiome on Therapeutics
Vázquez-Baeza, Y., Callewaert, C., Debelius, J., Hyde, E., Marotz, C., Morton, J. T., Swafford, A., Vrbanac, A., Dorrestein, P. C., & Knight, R. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-042017-031849 · Cited by 79
Jayakumar, S., & Loomba, R. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15314 · Cited by 84
Novel perspectives on therapeutic modulation of the gut microbiota
McCarville, J. L., Caminero, A., & Verdu, E. F. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16637819 · Cited by 76
Obesity and Asthma: Microbiome–Metabolome Interactions
Shore, S. A., & Cho, Y. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0052ps · Cited by 90
An ecological framework to understand the efficacy of fecal microbiota transplantation
Xiao, Y., Angulo, M. T., Lao, S., Weiss, S. T., & Liu, Y.-Y. (2020) · Nature Communications · doi:10.1038/s41467-020-17180-x · Cited by 89
Jayasinghe, T. N., Chiavaroli, V., Holland, D. J., Cutfield, W. S., & O'Sullivan, J. M. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00015 · Cited by 77
Metadata
- Authors
- Alang, N., & Kelly, C. R.
- Affiliations
- Newport Hospital (US)
- Brown University (US)
- Corresponding author
- Alang, Neha
- ORCID
- Kelly, Colleen R.
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01-01
- Volume
- 2
- Issue
- 1
- Pages
- ofv004-ofv004
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC4438885
- OpenAlex
- W2121441667
- Cited by
- 403
- References
- 3
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 16 · 2023: 25 · 2022: 33 · 2021: 33 · 2020: 46 · 2019: 40 · 2018: 52 · 2017: 52 · 2016: 57 · 2015: 27
- FWCI
- 48.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, weight gain, donor obesity, Clostridium difficile infection, recurrent infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.